NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$52.9M
This Quarter Return
-5.6%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$52.9M
AUM Growth
+$52.9M
(+18%)
Cap. Flow
-$1.01M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Rocket Pharmaceuticals
RCKT
|
$1.01M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Passage Bio
PASG
$22.7M
| $20M | 37.74% | 2,497,922 | – | – |
|
2
Edgewise Therapeutics
EWTX
$1.51B
| $13.5M | 25.51% | 1,030,161 | – | – |
|
3
Arvinas
ARVN
$568M
| $11.7M | 22.04% | 1,585,721 | – | – |
|
4
Crinetics Pharmaceuticals
CRNX
$2.92B
| $4.06M | 7.66% | 141,000 | – | – |
|
5
Cogent Biosciences
COGT
$1.69B
| $1.8M | 3.4% | 250,765 | – | – |
|
6
Rallybio
RLYB
$22.4M
| $1.12M | 2.11% | 3,301,603 | – | – |
|
7
Alector
ALEC
$238M
| $475K | 0.9% | 339,569 | – | – |
|
8
Iterum Therapeutics
ITRM
$30.2M
| $343K | 0.65% | 345,020 | – | – |
|
|
9
Rocket Pharmaceuticals
RCKT
$354M
| – | – | -150,706 | Closed | -$1.01M |
|